Monazzah Akbar Sarwar
Clinical Assistant Professor, Pharmacy Practice
Email:
Related Sites:
About
Teaching and Supervision
Undergrad Resrch Pharm Pract (PMPR 12957), 1/12/2026 – 5/1/2026
Spec Project in Pharm Pract (PMPR 24240), 1/12/2026 – 5/1/2026
PMPR 380/390, 1/1/2026 – Present
PHAR 412, 11/17/2025 – Present
Drug Dispensing (PHAR 411), 11/17/2025 – Present
PHAR 362, 11/13/2025 – Present
PHAR 508 Recitation, 10/31/2025 – Present
PHAR 411, 8/28/2025 – Present
Spec Project in Pharm Pract (PMPR 390), 8/25/2025 – 12/5/2025
Selected Grants
A Phase I/II Randomized Placebo-Controlled, Double-Blind, Single-Center, Tolerability And Preliminary Efficacy Clinical Trial Of Recombinant Human Deoxyribonuclease (Rhdnase) Eye Drops In Patients With Ocular Graft-Vs.-Host Disease, Genentech Foundation for Biomedical Sciences., 6/3/2019 - 7/10/2020, No Obligated Amount Set; No Anticipated Amount Set
Dr. Lim's study - EEI pharmacy to compound as needed based on patient randomization, Dr. Jennifer Lim Brimonidine study., 4/1/2019 - 9/21/2022, No Obligated Amount Set; No Anticipated Amount Set
borad-spectrum immunomodulatory eye drop to treat patients with severe dry eye (Dr. Sandeep Jain's grant), National Institutes of Health., Date Not Set - Present, No Obligated Amount Set; No Anticipated Amount Set
Selected Publications
Dabre, Zeenal, Mun, Christine, Moon, Hyung-Geun, Mun, Jessica, Ascencio, Nancy, Shehadi, Jack, Sheth, Tejas, Hernandez, Diana, Sheth, Tanya, Byrne, Kiera, Sarwar, Monazzah, Jain, Sandeep. (2026). A post-HSCT ocular surface “Window of Opportunity for Pre-emptive ocular treatment (WinOP)” shows early inflammatory activation and an oGVHD-like molecular subset. The Ocular Surface, 42, 85-100. doi:10.1016/j.jtos.2026.07.002.
Abedi, Farshad, Kwon, Jeonghyun Esther, Araujo, Iskra, Yucel, Zarife J, Jung, Rebecca, Soleimani, Mohammad, An, Seungwon, Ghassemi, Mahmood, Anwar, Khandeker N, Arabpour, Zohreh, Sarwar, Monazzah A, Tu, Elmer Y, Hematti, Peiman, Joslin, Charlotte E, Mahmud, Nadim, Djalilian, Ali R. (2026). Safety and tolerability of topical mesenchymal stromal cell secretome in persistent corneal epithelial disease—a phase 1b clinical trial. Cytotherapy, 28, (11), 102958. doi:10.1016/j.jcyt.2026.102958.
Hightower, A, Halsey, J, Sowa, K, Kachlic, M Djuric, Sarwar, M Akbar. (2026). 310 Impact of Outpatient Pharmacist-Led Continuous Glucose Monitoring Management Programs on Glycemic Outcomes. Journal of the American Pharmacists Association, 66, (4), 103327. doi:10.1016/j.japh.2026.103327.
Dabre, Zeenal, Mun, Christine, Sheth, Tanya, Kim, Christian, Sarwar, Monazzah, Ungaretti, Natalie, Byrne, Kiera, Kaja, Simon, Jain, Sandeep. (2026). Corneal Fluorescein Staining in FDA-Reviewed Dry Eye Registrational Clinical Trials: Evidence of Limited Endpoint Responsiveness. Ophthalmic Research, 69, (1), 24-42. doi:10.1159/000550166.
Dabre, Zeenal G, Sheth, Tanya, Hernandez, Elias, Mun, Jessica, Hernandez, Diana, Ascencio, Nancy, Kim, Christian, Sarwar, Monazzah, Byrne, Kiera, Pradeep, Anubhav, Rondelli, Damiano, Mun, Christine, Jain, Sandeep. (2025). Ocular graft-versus-host disease: Experience, incidence, and treatment outcomes at a university-based tertiary care ophthalmology center. The Ocular Surface, 37, 219-226. doi:10.1016/j.jtos.2025.04.006.
Kim, Christain, Surenkhuu, Bayasgalan, Akbar Sarwar, Monazzah, Sheth, Tanya, Mun, Christine, Jain, Sandeep. (2024). Safety and Efficacy of Deoxyribonuclease I (DNase) Eye Drops for Ocular Graft vs Host Disease (oGVHD). Investigative Ophthalmology and Visual Science, 65, (7).
★ Mun, Christine S, Surenkhuu, Bayasgalan, Chen, Yi-Fan, Atassi, Nour, Mun, Jessica, Kim, Christian, Sheth, Tanya, Sarwar, Monazzah Akbar, Pradeep, Anubhav, Jain, Sandeep. (2024). Recombinant Deoxyribonuclease I Eye Drops for Ocular Graft Versus Host Disease: Results of a Randomized Clinical Trial. Eye & Contact Lens Science & Clinical Practice, 50, (5), 233-240. doi:10.1097/icl.0000000000001078.
★ Katz, Eitan A, Sunshine, Sarah, Mun, Christine, Sarwar, Monazzah, Surenkhuu, Bayasgalan, Pradeep, Anubhav, Jain, Sandeep. (2022). Combinatorial therapy with immunosuppressive, immunomodulatory and tear substitute eyedrops (“Triple Play”) in Recalcitrant Immunological Ocular Surface Diseases. The Ocular Surface, 23, 1-11. doi:10.1016/j.jtos.2021.11.002.
★ Kwon, Jieun, Surenkhuu, Bayasgalan, Raju, Ilangovan, Atassi, Nour, Mun, Jessica, Chen, Yi-Fan, Sarwar, Monazzah Akbar, Rosenblatt, Mark, Pradeep, Anubhav, An, Seungwon, Dhall, Nikhil, Mun, Christine, Jain, Sandeep. (2020). Pathological consequences of anti-citrullinated protein antibodies in tear fluid and therapeutic potential of pooled human immune globulin-eye drops in dry eye disease. The Ocular Surface, 18, (1), 80-97. doi:10.1016/j.jtos.2019.10.004.
Professional Leadership
PGY1 Community Resident Interviews, 2/1/2026 - Present
ICHP Ambulatory Care Network, Illinois Council of Health-System Pharmacists, 10/1/2025 - 10/1/2026
ICHP Ambulatory Care Network (ACN), 8/30/2025 - Present
Phlames Family Mentor, 5/1/2025 - Present
West Campus Flu Clinic, Taylor St/EEI Pharmacy, 9/9/2022 - 9/9/2022
Ambulatory Care Network, 4/7/2022 - 5/31/2023
COVID vaccine testing and challenge desensitizations, 2/1/2021 - 4/30/2021
Formulate leucovorin eye drops, 12/28/2020 - 12/28/2020
Transition to EPIC, 9/12/2020 - 4/30/2021
Notable Honors
2022, Best Encore poster presentation, Illinois Council of Health-System Pharmacists (ICHP)
Licensures and Certifications
BCSCP, BPS, Date Not Set - Present